We’re proud to share that Potter Clarkson has once again been ranked among the world’s leading patent firms in the IAM Patent 1000: The World’s Leading Patent Professionals 2025.
On 1 January 2025, a new and modernised Swedish Patent Act entered into force, replacing the Patent Act from 1967.
Formula 1 is on the cusp of a significant transformation, with the sport considering drastic changes for its next set of engine regulations. Ethan Silverstone, patent attorney and former F1 engineer, considers the strategic IP decisions going on behind the scenes.
Potter Clarkson is proud to support the launch of the £14 million Carbon-Loop Sustainable Biomanufacturing Hub (C-Loop), a major new UK initiative designed to transform industrial waste into valuable, sustainable products using engineered biology.
In a January 2025 judgment, the Court of Appeal upheld the judgment of the High Court (Patents Court) in the case of Merck Serono S.A. (Appellant) v The Comptroller-General of Patents, Designs, and Trade Marks (Respondent).
The Central Division (Munich) has handed down a significant revocation decision in the ongoing patent battle between NanoString v 10x Genomics and President and Fellows of Harvard College.
The CJEU has handled the Hungarian referral in case C-181/24 with a straightforward confirmation that an application for a SPC must be based on the first marketing authorisation for the product.
If your next invention is going to have the commercial impact it should, you will need to correctly identify, protect, exploit, and enforce it. This is exactly what Potter Clarkson’s patent attorneys in Copenhagen do.
The Supreme Administrative Court in the Czech Republic has asked the CJEU whether a substance classified as an excipient in a marketing authorisation can still be considered an active ingredient for an SPC application, and what information is needed for an additional active ingredient to be "specifically identifiable" based on the patent.
We are delighted to report that our client, Proteotype Diagnostics Ltd, has just been awarded a £1.5 million Cancer Mission Grant to advance the groundbreaking work they have been doing in early cancer detection with their innovative Enlighten™ test.
Did you know that lots of companies are looking to nature to make new textiles, construction materials, wound dressings, and other vital materials?
Pressures of climate change, resistance, regulatory pressures, and yield improvement require new crop protection molecules.
Anybody who has worked in a lab will know that getting a protocol to work isn’t as simple as just following the instructions printed in a journal. Even routine optimisation takes a lot of time, once you know the secret it’s easy to replicate, and protecting this knowledge can be very valuable to biotech companies.
In a press release earlier this month, the UK government unveiled several new announcements to drive innovation in science. This comes alongside a rallying call “to put science and technology at the very top of the UK’s priorities”.
The EU Parliament has voted on new legislature that could significantly shake up the patentability and commercialisation of gene-edited plants in Europe.